medigraphic.com
ISSN 1527-3172 (Electronic)

2014, Number 3-4

<< Back Next >>

MEDICC Review 2014; 16 (3-4)

Implementing ACCM critical care guidelines for septic shock management in a Cuban Pediatric Intensive Care Unit

Cartaya YJM, Rovira RLE, Segredo MY, Álvarez GI, Acevedo RY, Moya MA

Language: English
References: 52
Page: 47-54
PDF size: 152.02 Kb.


ABSTRACT

Introduction: Sepsis is the most common direct cause of death worldwide and septic shock the syndrome's most serious complication. In 2002, the pediatric intensive care unit of the José Luis Miranda Pediatric University Hospital in Santa Clara (Villa Clara Province), Cuba, began implementing the recently published guidelines of the American College of Critical Care Medicine (ACCM) for management of pediatric and neonatal septic shock, observing a drop in case fatality from 34.6% to 19% between the years 2003 and 2007. ACCM updated these Guidelines in 2007.
Objetive: Describe experiences with the use of the 2007 ACCM updated Guidelines and discuss their possible impact in reducing case fatality.
Methods: Between 2008 and 2010, a study was conducted of 280 children and adolescents, from newborns through 18 years, admitted to the pediatric intensive care unit with a diagnosis of septic shock. The diagnostic and therapeutic criteria used were those recommended in the ACCM's 2007 updated Guidelines. The dependent variable was case fatality. Independent variables were age, sex, comorbidity or prior chronic disease, origin and course of sepsis, hemodynamic state, blood glucose level, hyperglycemia, organ dysfunction, volume of fluid therapy administered, use of mechanical ventilation and therapeutic response.
Results: In the 3-year period, 28-day case fatality was 11.1% (31/280). A total of 45 patients had comorbidities, with 14 deaths and a case fatality rate of 31.1% vs. 7.2% (17/235) in previously healthy patients. Cold shock with a hemodynamic state of low cardiac output and high systemic vascular resistance predominated (68.9%), with low cardiac output and low systemic vascular resistance the least common type (12.5%), but the one with highest case fatality (34.4%). Hyperglycemia was present in 39.6% of patients, with 15.3% case fatality; case fatality was higher (25.6%) when hyperglycemia was in the 10–15.9 mmol/L range.
Fluid therapy of 40–100 mL/kg was administered in the first hour to 90% of patients, increasing to › 96% in the first 3–6 hours. The most common therapeutic response was fluid refractory, dobutamine responsive (39.3%). Mechanical ventilation was used in 33.9% of patients, with a case fatality of 30.5%. Cardiovascular, respiratory and hematologic dysfunctions were common. Failure of ≥4 organs raised case fatality to 77.8%.
Conclusions: Implementation of ACCM Guidelines facilitates timely, appropriate care for septic shock patients and contributes to lower case fatality. Early aggressive fluid therapy with support of vasoactive drugs, either singly or in combination, has a positive impact on patient outcomes. Similar studies with a larger number of patients are needed to corroborate these conclusions.


REFERENCES

  1. Watson RS, Carcillo JA. Scope and Epidemiology of Pediatric Sepsis. Pediatr Crit Care Med. 2005 May;6(3 Suppl):S3–5.

  2. Aneja R, Carcillo J. Differences between adult and pediatric septic shock. Minerva Anestesiol. 2011 Oct;77(10):986–92.

  3. Standage SW, Wong HR. Biomarkers for pediatric sepsis and septic shock. Expert Rev Anti Infect Ther. 2011 Jan;9(1):71–9.

  4. Wong HR. Genetics and genomics in pediatric septic shock. Crit Care Med. 2012 May;40(5):1618–26.

  5. Wong HR. Clinical review: sepsis and septic shock–the potential of gene arrays. Crit Care. 2012 Feb 8;16(1):204.

  6. Wong HR, Cvijanovich NZ, Allen GL, Thomas NJ, Freishtat RJ, Anas N, et al. Validation of a - egy for pediatric septic shock. Crit Care Med. 2011 Nov;39(11):2511–7.

  7. Phumeetham S, Chat-Uthai N, Manavathongchai M, Viprakasit V. Genetic association study of tumor necrosis factor-alpha with sepsis and septic shock in Thai pediatric patients. J Pediatr (Rio J). 2012 Sep–Oct;88(5):417–22. English, Portuguese.

  8. Larsen GY, Mecham N, Greenberg R. An emergency department septic shock protocol and care guideline for children initiated at triage. Pediatrics. 2011 Jun;127(6):e1585–92.

  9. Carcillo JA, Fields AI; American College of Critical Care Medicine Task Force Committee Members. Clinical practice parameters for hemodynamic support of pediatric and neonatal patients in septic shock. Crit Care Med. 2002 Jun;30(6):1365–78.

  10. de Oliveira CF. Early goal-directed therapy in treatment of pediatric septic shock. Shock. 2010 Sep;34 Suppl 1:44–7.

  11. Aneja RK, Varughese-Aneja R, Vetterly CG, Carcillo JA. Antibiotic therapy in neonatal and pediatric septic shock. Curr Infect Dis Rep. 2011 Oct;13(5):433–41.

  12. Angus DC, Linde-Zwirble WT, Lidicker J, Clermont G, Carcillo J, Pinsky MR. Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care. Crit Care Med. 2001 Jul;29(7):1303–10.

  13. Ngo NT, Cao XT, Kneen R, Willis B, Nguyen VM, Nguyen TQ, et al. Acute management of dengue shock syndrome: a randomized double- 15;32(2):204–13.

  14. Kutko MC, Calarco MP, Flaherty MB, Helmrich RF, Ushay HM, Pon S, et al. Mortality rates in pediatric septic shock with and without multiple organ failure. Pediatr Crit Care Med. 2003 Jul;4(3):333–7.

  15. González A, Valdés F, Fernández F, Ardisana O, Álvarez AI, Francisco JC. Comportamiento de la sepsis en terapia intensiva pediátrica. Rev Cub Med Int Emerg [Internet]. 2007 Sep [cited 2013 Sep 28];6(3):857–70. Available from: http://bvs.sld.cu/ revistas/mie/vol6_3_07/mie08307.htm. Spanish.

  16. Brierley J, Carcillo JA, Choong K, Cornell T, Decaen A, Deymann A, et al. Clinical practice parameters for hemodynamic support of pediatric and neonatal septic shock: 2007 update from the American College of Critical Care Medicine. Crit Care Med. 2009 Feb;37(2):666–88.

  17. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. 2001 SCCM/ESICM/ ACCP/ATS/SIS (2001) International Sepsis Apr;31(4):1250–6.

  18. Goldstein B, Giroir B, Randolph A; International Consensus Conference on Pediatric Sepsis. International pediatrics sepsis consensus con- - tion in pediatrics. Pediatric Crit Care Med. 2005 Jan;6(1):2–8.

  19. Han YY, Carcillo JA, Dragotta MA, Bills DM, Watson RS, Westerman ME, et al. Early reversal of pediatric septic shock by community physicians is associated with improved outcome. Pediatrics. 2003 Oct;112(4):793–9.

  20. Menif K, Bouziri A, Ben Jaballah N. [Manage- shock patient]. Tunis Med. 2011 Feb;89(2):132– 5. French.

  21. Maat M, Buysse CM, Emonts M, Spanjaard L, Joosten KF, de Groot R, et al. Improved survival in children with sepsis and purpura: effects of age, gender, and era. Crit Care. 2007;11(5):R112.

  22. Noguera L. Morbimortalidad por sepsis en niños gravemente enfermos. Med Crit Ter Intens. 2005;16(1):5–11. Spanish.

  23. Jaramillo JC, Marín A, Fernández M, Bareño J. Epidemiología de la sepsis en pediatría: primer Estudio Colombiano Multicéntrico. Rev CES Med. 2009;23(1):85–92. Spanish.

  24. Odetola FO, Gebremariam A, Freed GL. Patient and hospital correlates of clinical outcomes and resource utilization in severe pediatric sepsis. Pediatrics. 2007 Mar;119(3):487–94.

  25. Watson RS, Carcillo JA, Linde-Zwirble WT, Clermont G, Liddicker J, Angus DC. The epidemiology of severe sepsis in children in the United States. Am J Respir Crit Care Med. 2003 Mar 1;167(5):695–701.

  26. Sáez-Lloréns X, Vargas S, Guerra F, Coronado - ate outcome of pediatric patients with severe systemic infections. Pediatr Infect Dis J. 1995 Jul;14(7):557–61.

  27. Engel C, Brunkhorst FM, Bone HG, Brunkhorst R, Gerlach H, Grond S, et al. Epidemiology of sepsis in Germany: results from a national prospective multicenter study. Intensive Care Med. 2007 Apr;33(4):606–18.

  28. Ceneviva G, Paschall JA, Maffei F, Carcillo - tory pediatric septic shock. Pediatrics. 1998 Aug;102(2):e19.

  29. Furnary AP, Braithwaite SS. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. Am J Cardiol. 2006 Aug 15;98(4):557–64.

  30. Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 Mar;32(3):858–73.

  31. Dellinger R, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, et al. Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock: 2008. Intensive Care Med. 2008 Jan;34(1):17–60.

  32. Dellinger R, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, et al. Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock. Crit Care Med. 2013 Feb;41(2):580–637.

  33. Branco RG, Garcia PC, Piva JP, Casartelli CH, Seibel V, Tasker RC. Glucose level and risk of mortality in pediatric septic shock. Pediatric Crit Care Med. 2005 Jul;6(4):470–2.

  34. Verhoeven JJ, den Brinker M, Hokken-Koelega AC, Hazelzet JA, Joosten KF. Pathophysiological aspects of hyperglycemia in children with meningococcal sepsis and septic shock: a prospective, observational cohort study. Crit Care. 2011;15(1):R44.

  35. Mora E, Casado J, García J, González N, Monleón M, Serrano A. Multiorgan dysfunction in children: A review of 173 cases. Intensive Care Med. 1996;22:S168.

  36. Tantaleán JA, León RJ, Santos AA, Sánchez E. Multiple organ dysfunction syndrome in children. Pediatr Crit Care Med. 2003 Apr;4(2):181–5.

  37. Goh A, Lum L. Sepsis, severe sepsis and septic shock in paediatric multiple organ dysfunction syndrome. J Paediatr Child Health.1999 Oct;35(5):488–92.

  38. Stoner MJ, Goodman DG, Cohen DM, Fernan- pediatrics: testing the American College of Critical Care Medicine guideline. Ann Emerg Med. 2007 Nov;50(5):601–7.

  39. Wills BA, Nguyen MD, Ha TL, Dong TH, Tran TN - tions for resuscitation in dengue shock syndrome. N Engl J Med. 2005 Sep 1;353(9):877–89.

  40. Maitland K, Kiguli S, Opoka RO, Engoru C, Olu- - id bolus in African children with severe infection. N Engl J Med. 2011 Jun 30;364(26):2483–95.

  41. Chopra A, Kumar V, Dutta A. Hypertonic ver- atric septic shock. Indian J Pediatr. 2011 Jul;78(7):833–7.

  42. Kissoon N, Orr RA, Carcillo JA. Updated American College of Critical Care Medicine--pediatric advanced life support guidelines for management of pediatric and neonatal septic shock: relevance to the emergency care clinician. Pediatr Emerg Care. 2010 Nov;26(11):867–9.

  43. Ruza F, García S, Muñoz JI. Terapéutica hemodinámica. In: Ruza F, editor. Cuidados Intensivos Pediátricos. 3rd ed, Vol. 1. Madrid: Editorial Norma Capitel; 2003. Chapter 19. Spanish.

  44. Laitinen P, Happonen JM, Sairanen H, Peltola K, Rautiainen P, Korpela R, et al. Amrinone vs dopamine-nitroglycerin after reconstructive surgery for complete atrioventricular septal defect. J Cardiothorac Vasc Anesth. 1997 Dec;11(7):870–4.

  45. Jain P, Bansal A. Epinephrine in pediatric septic shock: does the algorithm speak what the recommendations say? Crit Care Med. 2010 Apr;38(4):1237–8.

  46. Montalván GL. Epinefrina en el estado de choque séptico en pediatría: a propósito de un debate. Rev Cubana Pediatr [Internet]. 2010 Sep [cited 2013 Sep 28];82(3):89–91. Available from: http://scielo.sld.cu/scielo.php ?script=sci_arttext&pid=S0034-75312010000 300011&lng=es. Spanish.

  47. Sakr Y, Reinhart K, Vincent JL, Sprung CL, Moreno R, Ranieri VM, et al. Does dopamine Results of the Sepsis Occurrence in Acutely III Patients (SOAP) Study. Crit Care Med. 2006 Mar;34(3):589–97.

  48. Liet JM, Boscher C, Gras-Leguen C, Gournay V, Debillon T, Rozé JC. Dopamine effects on pulmonary artery pressure in hypotensive preterm infants with patent ductus arteriosus. J Pediatr. 2002 Mar;140(3):373–5.

  49. Morimatsu H, Singh K, Uchino S, Bellomo R, Hart G. Early and exclusive use of norepinephrine in septic shock. Resuscitation. 2004 Aug;62(2):249–54.

  50. Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, et al. Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock. Pharmacother. 2004 Aug;24(8):1002–12.

  51. Pollack MM, Patel KM, Ruttimann UE. PRISM III: An updated Pediatric Risk of Mortality Score. Crit Care Med. 1996 May:24(5):743–52.

  52. Leteurte S, Martinot A, Duhamel A, Proulx F, Grandbastien B, Cotting J, et al. Validation of the paediatric logistic organ dysfunction (PELOD) score: Prospective, observational, multicentre study. Lancet. 2003 Jul 19;362(9379):192–7.




2020     |     www.medigraphic.com